Other names: Azilect
Categories: Prescription Medication
Description:
Rasagiline (Azilect®) is a MAO-B inhibitor used in Parkinson’s disease to help preserve dopamine levels in the brain. It can be prescribed alone in the early stages for mild symptom control or added to levodopa later to reduce “wearing-off” effects. Benefits are generally modest, but it can improve motor function and daily activities. Rasagiline is usually well tolerated, with possible side effects including headache, joint pain, insomnia, and nausea. Because it works once daily and has fewer dietary restrictions than older MAO inhibitors, it is a convenient option for long-term management.
Treatment For:
AI generated Summary: Based on the provided information, there are no user reviews available for the treatment 'Rasagiline' against 'Parkinson's Disease'. The effectiveness of this treatment cannot be determined without any user feedback or ratings. More data is needed to assess the efficacy of Rasagiline in managing Parkinson's Disease symptoms.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
